Considering its frequency, high mortality rate as well as many etiological mysteries colorectal cancer is a challenge to contemporary science. In our study we analyzed RER + and RER -phenotypes and their relations with clinical-pathological characteristics of sporadic colorectal cancers. We also analyzed genetic alterations of tumor suppressor genes as well as their relation with microsatellite instability. Th e study was based on  tumor samples and  samples of the surrounding healthy tissue of patients with colorectal cancer. According to Amsterdam Criteria and Bethesda Criteria / or , belonged in the group of sporadic colorectal cancer. Mononucleotide marker Bat  showed instability in ,; Bat  in , and Bat  in / , of tumor samples. Considering dinucleotide markers, TP  showed instability in , and DS in , of tumor samples. Genetic alterations in tumor suppressor genes were found in tumor tissue: NM  in , samples, p in ,, APC in ,, DCC in ,, RB in ,  and DCC  in ,. Our studies confi rmed that genetic instability had an important role in the development of tumor type. Our results showed that mononucleotide marker Bat  might be used for an easy and fast screening procedure in Bosnian population, because it exhibited high percent of microsatellite instability and was in relation with RER+ phenotype. Th is investigation showed that different genetic alterations may occur during cancer development in each individual patient' s tumor. Th ese changes result in MMR inactivation, which causes RER+ phenotype. Our results suggest a connection between alteration in some tumor suppressor genes and MSI phenotype of sporadic colorectal cancer in Bosnian population.
Introduction
Through its frequency, high mortality rate as well as with its many etiological unknowns, colorectal cancer is a challenge to contemporary science. In frequency, it follows right after lung cancer in men and breast cancer in women. Th e latest genetic information could be used in the near future for the prevention of colorectal cancer, its early diagnosis and for the selection of patients for the most suitable treatment () . Mutations in genes may stimulate early tumor development and cause multiple mutations in tumor tissues. Mutations in genes of DNA repair system discovered thus far, as well as the expansion of DNA repeating sequences may serve as early indicators for most of mutations that characterize tumor phenotype () . Cloning and molecular analysis provided proofs that the inactivation of one of MMR genes causes microsatellite instability (MSI) as well as positive replication error (RER +). Most authors set microsatellite instability in at least   of analyzed loci as criteria for RER+ phenotype () . RER+ phenotype is present in about  at hereditary non-polyposis colorectal cancer and in about - of sporadic colorectal cancer patients. In HNPCC, mutations are usually found in hMLH and hMSH genes, which result in loss of heterozygosity that inactivates MMR genes. Th ey were also found in sporadic colorectal cancers with RER+ phenotype. Mutations are present in hMSH, hMLH, hMSH and GTBP genes in majority of HNPCC patients, and in hPMS and hPMS genes in minority (,,) . International Collaborative Group (ICG) published criteria for determination of microsatellite instability in colorectal cancer () . When the panel of  microsatellite loci is used in analysis, the tumor has microsatellite instability if two or more markers are unstable. Microsatellite panel must include mononucleotide markers: Bat  and Bat , as well as DS from the group of dinucleotide markers. These are Bethesda Criteria that determine which colorectal cancers may be tested for microsatellite instability () . According to these criteria, tumors are classified with regard to microsatellite instability:
• MSI -L low rank tumors that show MSI in less than - loci;
• MSI-H high rank tumors that show MSI in over  loci and have positive replication error -RER+, and • MSS-tumors with stable microsatellite loci. In  in Amsterdam, International Collaborative Group established Amsterdam Criteria that are applied in diagnosing HNPCC families () . Th ese criteria were also used in our study. Generally, when the other allele of tumor suppressor gene is lost or inactivated in a somatic cell, it is regarded as loss of heterozygosity (LOH), which presents a marker for localization and identifi cation of tumor suppressor gene () . Authors established around   loss of heterozigosity in DCC genes in colorectal cancers, while other reports state  LOH () . Loss of DCC gene in gastric cancers is about  (). Loss of heterozygosity in p in colorectal cancer is about  () , and LOH in APC gene is about  () . In our study we analyzed RER + and RER -phenotype and their relation with clinicopathological characteristics in sporadic colorectal cancers. Also, we analyzed genetic alterations of tumor suppressor genes as well as their relation with microsatellite instability.
Materials and Methods
Our study was based on  samples of tumor and surrounding healthy tissue of patients with colorectal cancer. The samples were collected at Gastroenterological and Surgical Clinic of University Clinics Center in Tuzla (Bosnia and Herzegovina). Both tumor and healthy surrounding tissue was formalin fi xed, and thereafter embedded in paraffi n blocks. Method of genomic DNA isolation is based on de-paraffi nisation of tissue sections and cell proteolyses with proteinase K () . Fluorescent chain synthesis of DNA is a method with very broad application in tumor detection, and it is especially important in determination of microsatellite instability (MSI) and loss of heterozygosity (LOH) of tumor suppressor genes. We used mononucleotide and dinucleotide microsatellite markers in the detection of microsatellite instability. In the group of mononucleotide markers we used BAT, BAT and BAT, and in the group of dinucleotide markers: DS and TP . For LOH detection, we used intragene markers for the following tumor suppressor genes: NM, p, APC, RB, DCC and DCC () . Amplifi cation reactions contained: , μl  x buff er; μl DNA (- ng);  μl MgCl (mM); , μl of each dNTP (, mM); ,μl AmpliTaq Gold polymerase (, U; Perkin-Elmer); μl forward (, pmol) and μl reverse primer (, pmol) and sterile water until fi nal volume of μl. PCR was performed in a PCR Thermocycler  (PerkinElmer). PCR conditions included an initial denaturation step at °C for  min,  cycles of denaturation at °C for  s, annealing at °C for  s and elongation at °C for  s, and fi nal extension at °C for  min. Amplified PCR products were separated in an automated sequencer  ABI PRISM, Genetic Analyser  (Perkin Elmer), which enabled separation and quantification of DNA fragments according to the principles of 
Results

Analysis of genetic instability at microsatellite loci and RER phenotype of sporadic colorectal cancers
In the total sample of  patients  or , belong to sporadic colorectal cancer, according to Amsterdam Criteria and Bethesda Criteria. Mononucleotide marker Bat  showed instability in / (,); Bat  in / (,) and Bat  in / (,) of tumor samples ( Figure  ).
In the group of dinucleotide markers, TP  showed instability in / (,) and DS in / (,) of tumor samples. With regard to instability among mononucleotide markers the diff erence was found signifi cant (p<,), however, the diff erence between dinucleotide markers was not (p>,). Signifi cance test showed significant differences between mononucleotide and dinucleotide markers with regard to microsatellite status (p<,). Number of unstable microsatellite loci in certain sample defi nes its RER phenotype as either RER+ or RER-. Th e study showed that / (,) of tumor samples belong to RER+ phenotype, and / (,) belong to RER-phenotype. Th ere is a signifi cant diff erence between RER+ and RER-tumor phenotype in frequency of unstable microsatellite loci (p<,). In the group of tumors with RER+ phenotype microsatellite instability was established at mononucleotide marker Bat  in / (,), and dinucleotide marker TP in / (, ) of samples. In the group of tumors with RER-phenotype, mononucleotide marker Bat  showed instability in / (,) cases, and dinucleotide marker TP  as well as Bat  showed instability in / (,) tumor tissues. There is a significant difference between mononucleotide and dinucleotide markers with regard to RER status (p<,). Statistically signifi cant diff erences were also found among dinucleotide markers with regard to RER phenotype (p=,). Analysis of some clinicopathological parameters (sex, ages, tumor localization, hystopathological classifi cation) showed that colorectal Figure ) . In mucionus adenocarcinoma loss of heterozygosity was more frequent at locus TP in / (), in adenocarcinoma allele loss was present at NM in / (,) ( Table ) . No significant difference between loss of heterozygosity in tumor suppressor gene and clinicopatholoical characteristics was established (p>,).
Discussion
There is a belief that changes in the system of MMR genes cause not only HNPCC development, but sporadic collorectal cancer as well () .Analysis of MSI status in Japanese patients () showed microsatellite instability in  tumors while  showed that they belong to MSI-H tumors. Other authors () () . Previous studies confi rmed Bat  and Bat  to be highly sensitive (in  and  cases respectively) for the detection of microsatellite instability in adenomas and cancers () . In our study mononucleotide marker Bat  showed instability in , cases; Bat  in , and Bat  was highly unstable in as many as , of tumor samples ( Figure  ) . Among dinucleotide markers, TP showed instability in , and DS in , of tumor samples. Study of Hong Kong patients showed  frequency of RER+ phenotype in sporadic collorectal cancers () . Some studies found that , tumors belong to RER + phenotype () or that RER + phenotype ranked between  and  () . Also, replication errors were found in (,) in the left segment of colon. Age diff erences were not signifi cant (age of tumor appearing was between  and ) (). Further studies showed that in   cases microsatellite instability was registered at all of the fi ve tested dinucleotide markers (DS,etc.) Frequency of MSI positive status in proximal colon was ,, in distal , and in rectum ,. High MSI-H showed a signifi cant correlation with proximal tumor localization. All the tumors found in rectum had MSI-L status. Also, the analysis showed no correlation between clinicopathological characteristics and MSI tumor status () . Results of our studies are in agreement with previous studies. Analysis of some clinicopathological parameters (sex, ages, tumor localization, histo-pathological classification) showed the dominance of males with , and persons over  years of age with ,. Tumors are located in the left-side (rectum and sigma region) ,, and , of samples were adenocarcinomas. Analysis showed no signifi cant diff erence between RER+ and RER-tumors with regard to age. In RERgroup the average age was about , years and , years in RER+ group () . Further studies established a relation between RER phenotype and histo-pathological variables in patients from Hong Kong. Th ere is no signifi cant diff erence between RER+ phenotype and the localization of tumor which is usually right-sided. Th ere is a signifi cant diff erence with regards to sex and age. Th e data suggest that RER+ phenotype is more frequent in males. Also, the data show that younger patients under  years of age had RER+ tumor phenotype and that the diff erence between RER+ and RER-tumor phenotype is signifi cant () . RER+ tumors were found in patients  years old, while RER-tumors were found in older females about  years old. Th ese studies showed a significant relation between RER+ tumors and tumor localization in proximal colon. Th ere is no signifi cant diff erence between these two groups of tumors and RER-tumor localization () . Results of our studies (Table ) concur with previous reports that RER+ phenotype was more frequent in age group under  with ,. Majority of RER+ tumors were left-side tumors ,, and these appear in females in ,. RER-phenotype was more frequent in males in ,; in the age group over  in  and in , those tumors were located in the right side. Statistical analysis showed no signifi cant diff erence between RER+ and RER-tumor phenotypes with regard to clinicopathological parameters (p>,). Previous studies have shown an inverse relation between RER phenotype and loss of heterozygosity at chromosomes q, p and q () . In Hong Kong patients, RER+ tumor phenotype, which was compared with RER-tumor phenotype, showed low level of mutations in the form of LOH at tumor suppressors as well as p in , MCC in , DCC in  and APC in . High frequencies of allele loss of over   () were found at DCC and APC locus, but at RB  locus the frequency was exceptionally low, less than . In Caucasian and Japanese patients, loss of heterozygosity at q chromosome was over , and loss of heterozygosity at APC was between  and  () . Our studies showed the highest frequency of genetic alterations in tumor suppressor gene NM  which were identifi ed in , samples. () . Loss of heterozygosity was detected in malignant biopsies of gastro-esophagus in   cases. LOH in APC, DCC tumor suppressors as well as in MSH loci can be detected in histologically normal tissues and in adenocarcinomas () . Th ose are potential markers for early neoplastic progression. Microsatellite instability in three loci simultaneously was found in , cases, specifi cally, in the group of patients with average age of  years. Th is fi nding suggests a very important role of MMR gene in cancer pathogenesis at this age () . Th eir research showed loss of heterozygosity in the region of DCC tumor suppressor in , patients at the age of . Th e analysis of genetic alterations and microsatellite instability revealed no correlation with clinicopathological characteristics. No patient had family history of colorectal cancer and all tumors were located in the left-side. Th ere are two large groups of colorectal cancers which can be individualized and which suggest correlation among molecular, clinical and pathological forms of tumors () . Th e fi rst group consists of tumors with LOH in  cases, which are located in distal part of colon. The second group includes tumors with pronounced microsatellite instability without allele loss. Th ese tumors make  of all colorectal cancers and in   belong to the group of right-side tumors. Authors conclude that these tumors had better prognosis. Our analysis of genetic alterations and clinicopathological characteristics showed loss of heterozygosity at p in , cases, and that allele loss at NM  was found in males in , samples. In the age group under , loss of heterozygosity was the most prominent at p gene in , samples, and in the age group over  loss of heterozygosity appeared at NM  and APC genes in , samples ( Figure ) .
With regards to the tumor localization, loss of heterozygosity was more frequent in left-sided tumors at APC gene in , samples. In right-sided tumors allele loss at p was ,. In mucionous adenocarcinoma, loss of heterozygosity was found at locus TP  in  samples. In adenocarcinoma allele loss was found at NM  in , cases (Table  ) . There is no significant difference between loss of heterozygosity in tumor suppressor genes with regard to clinicopathological characteristics (p>,). In a previous study () RER status and loss of heterozygosity at p, p, q, p, p and q chromosomes were analyzed. Th e authors used CA repeat motive sequence of dinucleotide markers. Th ey found higher frequency of LOH in RER-tumor phenotype (,) than in RER+ tumor phenotype (,) . Analysis of microsatellite instability and loss of heterozygosity of p and APC tumor suppressor genes in  colon and rectum tumors confi rmed that  tumors belong to RER+ phenotype () . Loss of heterozygosity at p was found in  samples and at APC in  samples. Authors established lower frequency of RER+ phenotype in rectal tumors with earlier loss of heterozygosity. In colorectal tumors with the same phenotype, mutations in APC locus were less frequent than mutations in p. Tumors with RER-phenotype and no loss of heterozygosity can still develop as a result of carcinogenesis model. Some authors found loss of heterozygosity at p chromosome in  of rightsided and  of left-side tumors. RER+ phenotype was found in  of right-sided tumors and   of left-sided tumors (, ) . Th e heterogeneous pattern of tumor mutations suggests that multiple alternative genetic pathways to colorectal cancer exist and accepted genetic model of cancer development is not representative of major tumors () . Our results show that the LOH in APC is specially frequent in tumors that belong to RER+ phenotype (,), and that the least frequent were
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